Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |